Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes

NCT00511732 ·Status: COMPLETED ·Phase: PHASE2

Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler

NCT01490762 ·Status: COMPLETED ·Phase: PHASE1

To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.

NCT00419302 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)

NCT01021891 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler

NCT01196104 ·Status: TERMINATED ·Phase: PHASE3

A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus

NCT00642538 ·Status: COMPLETED ·Phase: PHASE1

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

NCT00642616 ·Status: TERMINATED ·Phase: PHASE3

A 2-Month Safety Follow-Up Trial

NCT00741429 ·Status: COMPLETED

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

NCT00309244 ·Status: COMPLETED ·Phase: PHASE3

An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial

NCT00754624 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study

NCT03143816 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes

NCT01544881 ·Status: COMPLETED ·Phase: PHASE1

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

NCT00934414 ·Status: COMPLETED ·Phase: PHASE2

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

NCT00332826 ·Status: TERMINATED ·Phase: PHASE3

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

NCT00308308 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake

NCT00747006 ·Status: TERMINATED ·Phase: PHASE2

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

NCT00673621 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study in Healthy Volunteers

NCT01365117 ·Status: COMPLETED ·Phase: PHASE1

Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes

NCT00511719 ·Status: COMPLETED ·Phase: PHASE2

A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro

NCT00662857 ·Status: COMPLETED ·Phase: PHASE2

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.

NCT00424437 ·Status: COMPLETED ·Phase: PHASE3

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

NCT07112339 ·Status: RECRUITING ·Phase: PHASE4

Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

NCT04292535 ·Status: COMPLETED ·Phase: PHASE2

PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)

NCT02485327 ·Status: COMPLETED ·Phase: PHASE1

Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes

NCT01189422 ·Status: TERMINATED ·Phase: PHASE1